Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
… Therefore, the BioMS-eu (http://www.bioms.eu ) network published in 2009 “a consensus
protocol for the standardization of cerebrospinal fluid collection and biobanking” and updated it …
protocol for the standardization of cerebrospinal fluid collection and biobanking” and updated it …
[HTML][HTML] … vein cross-sectional area and cerebrospinal fluid pulsatility in the aqueduct of sylvius: a comparative study between healthy subjects and multiple sclerosis …
… with increased cerebrospinal fluid (CSF) pulsatility in the aqueduct of Sylvius in multiple
sclerosis (… However, the authors confirm that these competing interests do not alter the authors' …
sclerosis (… However, the authors confirm that these competing interests do not alter the authors' …
Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis
RO Weller - Journal of neuropathology and experimental …, 1998 - academic.oup.com
Extracellular fluid in the central nervous system (CNS) is composed of cerebrospinal fluid (CSF),
derived from the choroid plexus, and of interstitial fluid (ISF) in gray and white matter. …
derived from the choroid plexus, and of interstitial fluid (ISF) in gray and white matter. …
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
M Andersson, J Alvarez-Cermeno… - Journal of Neurology …, 1994 - jnnp.bmj.com
… Concerted Action for Multiple Sclerosis (Charcot Foundation) organised five workshops to
discuss CSF analytical standards in the diagnosis of multiple sclerosis. This consensus report …
discuss CSF analytical standards in the diagnosis of multiple sclerosis. This consensus report …
[HTML][HTML] … OF CEREBROSPINAL FLUID DYNAMICS USING PHASE-CONTRAST MAGNETIC RESONANCE IMAGING IN ASSESSMENT OF MULTIPLE SCLEROSIS …
A El-Galil, E Mohamed… - Al-Azhar Medical …, 2021 - journals.ekb.eg
… The altered cerebral flow physiology may be used to differentiate active versus chronic
disease. These findings may support the venous theory in MS patients, but may also be …
disease. These findings may support the venous theory in MS patients, but may also be …
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis
… profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients. … MR
T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis …
T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis …
Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic
… primary progressive multiple sclerosis CSF … multiple sclerosis are antibody-mediated and
pathogenically distinct from relapsing-remitting and secondary progressive multiple sclerosis. …
pathogenically distinct from relapsing-remitting and secondary progressive multiple sclerosis. …
[HTML][HTML] Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis
MJ Noga, A Dane, S Shi, A Attali, H van Aken… - Metabolomics, 2012 - Springer
… Affected pathways include nitric oxide synthesis, altered energy metabolism, polyamine …
agreement with established knowledge on EAE and multiple sclerosis. However, in some cases …
agreement with established knowledge on EAE and multiple sclerosis. However, in some cases …
Abnormalities of cerebral perfusion in multiple sclerosis
W Rashid, LM Parkes, GT Ingle, DT Chard… - Journal of Neurology …, 2004 - jnnp.bmj.com
Background: Measuring perfusion provides a potential indication of metabolic activity in brain
tissue. Studies in multiple sclerosis (MS) have identified areas of decreased perfusion in …
tissue. Studies in multiple sclerosis (MS) have identified areas of decreased perfusion in …
Body fluid biomarkers in multiple sclerosis
M Comabella, X Montalban - The Lancet Neurology, 2014 - thelancet.com
… multiple sclerosis can benefit from the use of biomarkers because of the disease's inherent
heterogeneity. Biomarkers in multiple sclerosis … unmet need in multiple sclerosis, and large …
heterogeneity. Biomarkers in multiple sclerosis … unmet need in multiple sclerosis, and large …